FRET and BRET-Based Biosensors in Live Cell Compound Screens
Live cell compound screening with genetically encoded fluorescence or bioluminescence-based biosensors offers a potentially powerful approach to identify novel regulators of a signaling event of interest. In particular, compound screening in living cells has the added benefit that the entire signaling network remains intact, and thus the screen is not just against a single molecule of interest but against any molecule within the signaling network that may modulate the distinct signaling event reported by the biosensor in use. Furthermore, only molecules that are cell permeable or act at cell surface receptors will be identified as “hits,” thus reducing further optimization of the compound in terms of cell penetration. Here we discuss a detailed protocol for using genetically encoded biosensors in living cells in a 96-well format for the execution of high throughput compound screens and the identification of small molecules which modulate a signaling event of interest.
Key wordsLive cell compound screening Genetically encoded biosensor Cell signaling Fluorescence resonance energy transfer Bioluminescence
- 4.Zhang JH, Chung TDY, Olderburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4(2)Google Scholar
- 11.Tian H, Ip L, Luo H, Chang DC, Luo KQ (2007) Br J Pharm 150(3):321–324Google Scholar
- 13.Jiang LI, Collins J, Davis R, Lin KM, DeCamp D, Roach T, Hsueh R, Rebres RA, Ross EM, Taussig R, Fraser I, Sternweis PC (2007) Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway. J Biol Chem 282(14):10576Google Scholar
- 19.Herbst KJ, Allen MD, Zhang J (2009) The cAMP-dependent protein kinase inhibitor H-89 attenuates the bioluminescence signal produced by Renilla luciferase. PLoS One 4(5)Google Scholar